Celltrion, Juno establish biosimilar partnership

Pharma |  News | 0 Comment | 18 Oct, 2019

Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing partnership, covering the biosimilar products Herzuma (biosimilar trastuzumab), ...Read more

CNMPA approves Eisai's antiepileptic drug

Pharma |  News | 0 Comment | 18 Oct, 2019

Tokyo headquartered Eisai Co., Ltd. has received a New Drug Approval for its in-house discovered and developed antiepileptic drug (AED) Fycompa® (perampanel) from the China Nationa...Read more

Roche reports strong sales growth in 2019

Pharma |  News | 0 Comment | 17 Oct, 2019

Commenting on the Group’s results, Roche CEO Severin Schwan said: “The uptake of our newly introduced medicines is very strong. We are successfully entering new disease areas an...Read more

BioIVT Acquires PPA Research Group enhancing its R&D capabilities

Pharma |  News | 0 Comment | 17 Oct, 2019

BioIVT, a leading provider of research models and services for drug and diagnostic development, on 16 Oct 2019, announced that it has acquired PPA Research Group, Inc., a human hematologic ...Read more

GC Pharma, Vaxess team up for influenza vaccine smart release patch

Pharma |  News | 0 Comment | 17 Oct, 2019

South Korea headquartered GC Pharma, a leading manufacturer of influenza vaccines with a global reach, and US based Vaxess, an innovative biotechnology company developing the MIMIX smart re...Read more

Certara Celebrates 20th Anniversary of the Simcyp Simulator Consortium

Pharma |  News | 0 Comment | 17 Oct, 2019

Certara®, the global model-informed drug development and decision support leader, today announced that it is celebrating the 20th anniversary of its Simcyp® Consortium.  ...Read more

Astellas transfers three products in Asia region to Daiichi Sankyo

Pharma |  News | 0 Comment | 17 Oct, 2019

Astellas Pharma Inc. has announced that subsidiaries of Astellas will transfer their marketing authorizations, trademark, and related contracts for “Nasea (5HT3 receptor antagoni...Read more

Granules India to divest stake in Joint Venture in China

Pharma |  News | 0 Comment | 17 Oct, 2019

Granules India Limited, has announced its intention to divest its entire equity shareholding in Granules Biocause Pharmaceuticals Co. Ltd. by selling its stake to joint venture partner. Gra...Read more

Takeda divests select OTC to Acino for over $200M

Pharma |  News | 0 Comment | 16 Oct, 2019

Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a ...Read more

STA to market sarcoma drug in Australia, NZ, SE Asia

Pharma |  News | 0 Comment | 16 Oct, 2019

Independent pharmaceutical company Specialised Therapeutics Asia (STA), headquartered in Singapore, has signed a new license deal, enabling it to provide a global advanced sarcoma therapy t...Read more

Eppendorf CryoCube® F101h ULT freezer: Compact green -80°C

Pharma |  News | By Ankit Kankar | 0 Comment | 14 Oct, 2019

Hamburg, October 2019  By combining longevity and quality with sustainability aspects, the CryoCube F101h is the personal below-the-bench ULT freezer. 101 L of -80°C can be filled...Read more

Shionogi to develop treatment for mycobacterial diseases

Pharma |  News | 0 Comment | 15 Oct, 2019

Japanese major research-driven pharmaceutical company Shionogi & Co., Ltd. has announced that it has entered into a new license agreement with US headquartered Hsiri Therapeut...Read more

CMAB Biopharma establishes exclusive partnership with BJ Bioscience

Pharma |  News | 0 Comment | 14 Oct, 2019

CMAB Biopharma (Suzhou) Inc., a pure-play biologics CDMO and BJ Bioscience Inc., an innovative biopharmaceutical enterprise, has announced a comprehensive strategic agreement for the develo...Read more

Japan issues GMP Certificate to Lupin’s Mandideep facility

Pharma |  News | 0 Comment | 11 Oct, 2019

Pharma major Lupin has announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility...Read more

Viela Bio to develop autoimmune drug for nine Asian regions

Pharma |  News | 0 Comment | 11 Oct, 2019

US based Viela Bio, Inc. and Japanese firm Mitsubishi Tanabe Pharma Corporation have announced a collaboration focused on the development and commercialization of inebilizumab – Viela...Read more

Daiichi Sankyo launches new drug for AML treatment

Pharma |  News | 0 Comment | 11 Oct, 2019

Daiichi Sankyo Company, Limited has announced the launch of VANFLYTA® (quizartinib), an oral FLT3 inhibitor, in Japan for the treatment of adult patients with relapsed/refractory F...Read more

Innovent, Chi-Med expand global collaboration for solid tumor treatment

Pharma |  News | 0 Comment | 11 Oct, 2019

Innovent Biologics, Inc. and Hutchison China MediTech Limited (Chi-Med) have announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent'...Read more

CTFH, Insilico Medicine enter Al drug discovery collaboration

Pharma |  News | 0 Comment | 10 Oct, 2019

Insilico Medicine, a Hong Kong headquartered company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug ...Read more